AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wally who wrote (769)	8/25/1998 4:17:00 AM
From: Richard Haugland	Read Replies (1) of 1728

Wally, a longer response is in my post techstocks.com Assuming that AFFX can both practice and enforce its broad patent on high density arrays, it seems to me that they have a controlling interest in this high-throughput technology. Of course, one must still be able to manufacture and sell the product at a profit. Certainly, being one of the first companies in the industry gives AFFX the strength of an established patent portfolio. I feel that the HYSQ patent disputes are what are now holding AFFX back. HYSQ has a relationship with Perkin-Elmer (PKN), which gives them some strength in defending their position but from what I have been able to assess, the technology covered in the HYSQ patents is not dominant over that of AFFX. It now appears that it will be at least a year before the HYSQ matter will be resolved. In the meantime, AFFX is establishing new manufacturing facilities to cover what has been reported to be a backlog of orders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next